Genetic Testing for Rare Diseases: A Systematic Review of Ethical Aspects

被引:10
作者
Kruse, Judith [1 ]
Mueller, Regina [2 ]
Aghdassi, Ali A. [3 ]
Lerch, Markus M. [4 ]
Salloch, Sabine [5 ]
机构
[1] Univ Med Greifswald, Inst Eth & Hist Med, Greifswald, Germany
[2] Univ Tubingen, Inst Eth & Hist Med, Fac Med, Tubingen, Germany
[3] Univ Med Greifswald, Dept Med A, Greifswald, Germany
[4] LMU Munich Univ Hosp, Munich, Germany
[5] Hannover Med Sch, Inst Eth Hist & Philosophy Med, Hannover, Germany
关键词
genetic testing; rare diseases; orphan diseases; genetic councelling; ethics; HUNTINGTONS-DISEASE; ISSUES; DISCRIMINATION; DISORDERS; FAMILIES; GENOMICS; RISK;
D O I
10.3389/fgene.2021.701988
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Genetic testing is associated with many ethical challenges on the individual, organizational and macro level of health care systems. The provision of genetic testing for rare diseases in particular requires a full understanding of the complexity and multiplicity of related ethical aspects. This systematic review presents a detailed overview of ethical aspects relevant to genetic testing for rare diseases as discussed in the literature. The electronic databases Pubmed, Science Direct and Web of Science were searched, resulting in 55 relevant publications. From the latter, a total of 93 different ethical aspects were identified. These ethical aspects were structured into three main categories (process of testing, consequences of the test outcome and contextual challenges) and 20 subcategories highlighting the diversity and complexity of ethical aspects relevant to genetic testing for rare diseases. This review can serve as a starting point for the further in-depth investigation of particular ethical issues, the education of healthcare professionals regarding this matter and for informing international policy development on genetic testing for rare diseases.
引用
收藏
页数:14
相关论文
共 47 条
  • [41] Genomics: the implications for ethics and education
    Thomas, SN
    [J]. BRITISH MEDICAL BULLETIN, 1999, 55 (02) : 429 - 445
  • [42] Clinical application of genomic high-throughput data: Infrastructural, ethical, legal and psychosocial aspects
    Umbach, Nadine
    Beissbarth, Tim
    Bleckmann, Annalen
    Duttge, Gunnar
    Flatau, Laura
    Koenig, Alexander
    Kuhn, Jessica
    Perera-Bel, Julia
    Roschauer, Julia
    Schulze, Thomas G.
    Schweda, Mark
    Urban, Alexander
    Zimmermann, Anja
    Sax, Ulrich
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2020, 31 : 1 - 15
  • [43] Non-invasive prenatal diagnosis (NIPD) for single gene disorders: cost analysis of NIPD and invasive testing pathways
    Verhoef, Talitha I.
    Hill, Melissa
    Drury, Suzanne
    Mason, Sarah
    Jenkins, Lucy
    Morris, Stephen
    Chitty, Lyn S.
    [J]. PRENATAL DIAGNOSIS, 2016, 36 (07) : 636 - 642
  • [44] In Their Own Words: Reports of Stigma and Genetic Discrimination by People at Risk for Huntington Disease in the International RESPOND-HD Study
    Williams, Janet K.
    Erwin, Cheryl
    Juhl, Andrew R.
    Mengeling, Michelle
    Bombard, Yvonne
    Hayden, Michael R.
    Quaid, Kimberly
    Shoulson, Ira
    Taylor, Sandra
    Paulsen, Jane S.
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2010, 153B (06) : 1150 - 1159
  • [45] Working Group commissioned by the Ontario Genetic Testing Advisory Committee, 2016, US GEN WID SEQ UND R
  • [46] Paediatric genomics: diagnosing rare disease in children (vol 19, pg 325, 2018)
    Wright, Caroline F.
    FitzPatrick, David R.
    Firth, Helen V.
    [J]. NATURE REVIEWS GENETICS, 2018, 19 (05) : 327 - 327
  • [47] Reproductive options for families at risk of Osteogenesis Imperfecta: a review
    Zhytnik, Lidiia
    Simm, Kadri
    Salumets, Andres
    Peters, Maire
    Martson, Aare
    Maasalu, Katre
    [J]. ORPHANET JOURNAL OF RARE DISEASES, 2020, 15 (01)